'Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults'.

•Philadelphia chromosome–positive AML patients can benefit from TKI interim therapy along with standard chemotherapy to achieve complete remission.•Minimal residual disease negativity could be a predictor of better clinical outcome after allogeneic hematopoietic cell transplantation.•The presence of inv(16) in patients with Ph+ AML is associated with better survival outcome.